Prot#AK002-014: A Phase 2/3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of AK002 in Adult and Adolescent Patients with Active Eosinophilic Esophagitis

Project: Research project

Project Details

StatusActive
Effective start/end date1/8/21 → 1/8/24

Funding

  • Allakos, Inc. (AK002-014)